HK Stock MarketDetailed Quotes

01093 CSPC PHARMA

Watchlist
  • 5.770
  • -0.090-1.54%
Market Closed Apr 19 16:08 CST
68.79BMarket Cap10.61P/E (TTM)

CSPC PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
16.94%7.87B
11.73%27.87B
7.42%20.64B
Operating income
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
16.94%7.87B
11.73%27.87B
7.42%20.64B
Cost of sales
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
-33.14%-2.06B
-7.59%-6.73B
-4.77%-4.99B
Operating expenses
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
-33.14%-2.06B
-7.59%-6.73B
-4.77%-4.99B
Gross profit
-0.36%22.18B
-1.70%16.79B
-0.89%11.24B
-5.03%5.52B
5.31%22.26B
9.11%17.08B
7.73%11.34B
12.09%5.81B
13.11%21.14B
8.30%15.66B
Selling expenses
11.58%-9.14B
13.34%-7.03B
9.39%-4.9B
11.91%-2.49B
1.01%-10.34B
-4.32%-8.11B
-1.69%-5.41B
-7.77%-2.82B
-11.37%-10.44B
-5.82%-7.78B
Administrative expenses
-1.43%-1.19B
2.08%-855.97M
5.17%-535.64M
-1.07%-263.08M
-16.14%-1.17B
-16.82%-874.16M
-13.64%-564.82M
-20.08%-260.3M
-6.78%-1.01B
0.50%-748.27M
Research and development expenses
-21.17%-4.83B
-25.95%-3.68B
-22.27%-2.3B
-11.77%-1.01B
-16.14%-3.99B
-16.43%-2.92B
-16.81%-1.88B
-30.41%-901.52M
-18.78%-3.43B
-10.67%-2.51B
Special items of operating profit
-48.38%420.59M
-8.36%405.88M
-13.72%214.78M
164.60%41.86M
49.32%814.85M
-22.03%442.91M
-54.52%248.93M
-148.06%-64.8M
-6.64%545.69M
829.34%568.09M
Operating profit
-1.82%7.44B
0.27%5.63B
-0.47%3.71B
2.37%1.8B
11.47%7.57B
8.24%5.62B
2.38%3.73B
-1.68%1.76B
12.19%6.79B
25.34%5.19B
Financing cost
-4.04%-25.9M
-12.51%-16.88M
-10.29%-10.72M
-54.97%-4.43M
-224.78%-24.89M
-132.70%-15M
-103.22%-9.72M
-0.88%-2.86M
37.34%-7.66M
---6.45M
Share of profits of associates
3.40%-41.07M
29.06%-32.97M
39.72%-16.25M
-42.31%-12.05M
-77.91%-42.51M
-119.94%-46.48M
-38.43%-26.95M
38.39%-8.46M
-14.23%-23.89M
-73.08%-21.13M
Share of profit from joint venture company
-148.43%-13.13M
-113.24%-5.5M
-108.12%-2.26M
-131.76%-4.69M
-41.49%27.11M
15.51%41.56M
32.14%27.78M
46.54%14.77M
34.51%46.34M
17.92%35.98M
Special items of earning before tax
-31.63%32.86M
--32.86M
----
----
28.64%48.07M
----
----
----
-88.78%37.37M
-91.80%24.27M
Earning before tax
-2.54%7.39B
0.23%5.61B
-1.02%3.68B
0.97%1.78B
10.74%7.58B
7.18%5.6B
1.54%3.72B
-1.13%1.76B
7.14%6.85B
17.23%5.22B
Tax
2.48%-1.32B
5.98%-964.74M
9.95%-623.51M
5.39%-311.86M
-16.50%-1.35B
-24.40%-1.03B
-25.03%-692.38M
-15.08%-329.63M
0.26%-1.16B
6.18%-824.85M
After-tax profit from continuing operations
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
-4.23%1.43B
8.78%5.69B
22.99%4.4B
Earning after tax
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
-4.23%1.43B
8.78%5.69B
22.99%4.4B
Minority profit
41.74%199.37M
45.84%150.38M
49.57%91.05M
35.22%40.26M
69.59%140.66M
66.96%103.11M
30.80%60.88M
14.11%29.77M
19.59%82.94M
8.13%61.76M
Profit attributable to shareholders
-3.58%5.87B
0.60%4.49B
0.03%2.97B
1.73%1.43B
8.67%6.09B
3.06%4.47B
-3.15%2.97B
-4.55%1.4B
8.63%5.61B
23.23%4.34B
Basic earnings per share
-3.21%0.4947
0.93%0.3784
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
-4.07%0.1179
8.64%0.4689
23.21%0.3626
Diluted earnings per share
-3.21%0.4947
0.91%0.3783
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
-4.07%0.1179
8.64%0.4689
23.25%0.3626
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
Deloitte - Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte - Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte - Guan Huang Chen Fang Certified Public Accountants
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover 1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B16.94%7.87B11.73%27.87B7.42%20.64B
Operating income 1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B16.94%7.87B11.73%27.87B7.42%20.64B
Cost of sales -6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B-33.14%-2.06B-7.59%-6.73B-4.77%-4.99B
Operating expenses -6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B-33.14%-2.06B-7.59%-6.73B-4.77%-4.99B
Gross profit -0.36%22.18B-1.70%16.79B-0.89%11.24B-5.03%5.52B5.31%22.26B9.11%17.08B7.73%11.34B12.09%5.81B13.11%21.14B8.30%15.66B
Selling expenses 11.58%-9.14B13.34%-7.03B9.39%-4.9B11.91%-2.49B1.01%-10.34B-4.32%-8.11B-1.69%-5.41B-7.77%-2.82B-11.37%-10.44B-5.82%-7.78B
Administrative expenses -1.43%-1.19B2.08%-855.97M5.17%-535.64M-1.07%-263.08M-16.14%-1.17B-16.82%-874.16M-13.64%-564.82M-20.08%-260.3M-6.78%-1.01B0.50%-748.27M
Research and development expenses -21.17%-4.83B-25.95%-3.68B-22.27%-2.3B-11.77%-1.01B-16.14%-3.99B-16.43%-2.92B-16.81%-1.88B-30.41%-901.52M-18.78%-3.43B-10.67%-2.51B
Special items of operating profit -48.38%420.59M-8.36%405.88M-13.72%214.78M164.60%41.86M49.32%814.85M-22.03%442.91M-54.52%248.93M-148.06%-64.8M-6.64%545.69M829.34%568.09M
Operating profit -1.82%7.44B0.27%5.63B-0.47%3.71B2.37%1.8B11.47%7.57B8.24%5.62B2.38%3.73B-1.68%1.76B12.19%6.79B25.34%5.19B
Financing cost -4.04%-25.9M-12.51%-16.88M-10.29%-10.72M-54.97%-4.43M-224.78%-24.89M-132.70%-15M-103.22%-9.72M-0.88%-2.86M37.34%-7.66M---6.45M
Share of profits of associates 3.40%-41.07M29.06%-32.97M39.72%-16.25M-42.31%-12.05M-77.91%-42.51M-119.94%-46.48M-38.43%-26.95M38.39%-8.46M-14.23%-23.89M-73.08%-21.13M
Share of profit from joint venture company -148.43%-13.13M-113.24%-5.5M-108.12%-2.26M-131.76%-4.69M-41.49%27.11M15.51%41.56M32.14%27.78M46.54%14.77M34.51%46.34M17.92%35.98M
Special items of earning before tax -31.63%32.86M--32.86M--------28.64%48.07M-------------88.78%37.37M-91.80%24.27M
Earning before tax -2.54%7.39B0.23%5.61B-1.02%3.68B0.97%1.78B10.74%7.58B7.18%5.6B1.54%3.72B-1.13%1.76B7.14%6.85B17.23%5.22B
Tax 2.48%-1.32B5.98%-964.74M9.95%-623.51M5.39%-311.86M-16.50%-1.35B-24.40%-1.03B-25.03%-692.38M-15.08%-329.63M0.26%-1.16B6.18%-824.85M
After-tax profit from continuing operations -2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B-4.23%1.43B8.78%5.69B22.99%4.4B
Earning after tax -2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B-4.23%1.43B8.78%5.69B22.99%4.4B
Minority profit 41.74%199.37M45.84%150.38M49.57%91.05M35.22%40.26M69.59%140.66M66.96%103.11M30.80%60.88M14.11%29.77M19.59%82.94M8.13%61.76M
Profit attributable to shareholders -3.58%5.87B0.60%4.49B0.03%2.97B1.73%1.43B8.67%6.09B3.06%4.47B-3.15%2.97B-4.55%1.4B8.63%5.61B23.23%4.34B
Basic earnings per share -3.21%0.49470.93%0.37840.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489-4.07%0.11798.64%0.468923.21%0.3626
Diluted earnings per share -3.21%0.49470.91%0.37830.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489-4.07%0.11798.64%0.468923.25%0.3626
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor Deloitte - Guan Huang Chen Fang Certified Public Accountants------Deloitte - Guan Huang Chen Fang Certified Public Accountants------Deloitte - Guan Huang Chen Fang Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg